Author: David Randall

Cancer ‘Cures’ Sold Online: A Cruel and Harmful Scam

Cancer ‘Cures’ Sold Online: A Cruel and Harmful Scam

Beware of products claiming to cure cancer on websites or social media platforms, such as Facebook and Instagram. According to Nicole Kornspan, M.P.H., a consumer safety officer at the U.S. Food and Drug Administration (FDA), they’re rampant these days. “Anyone who suffers from cancer, or knows someone who does, understands the fear and desperation that can set in,”...

FDA Approval Marks First Immunotherapy for Recurrent Respiratory Papillomatosis

FDA Approval Marks First Immunotherapy for Recurrent Respiratory Papillomatosis

For Immediate Release: August 14, 2025 Today, the U.S. Food and Drug Administration approved Papzimeos (zopapogene imadenovec-drba), a first-of-its-kind non-replicating adenoviral vector-based immunotherapy for the treatment of adult patients with recurrent respiratory papillomatosis (RRP). RRP is a rare, chronic disease caused by persistent human papillomavirus...

FDA Streamlines Access to CAR T Cell Cancer Treatments

FDA Streamlines Access to CAR T Cell Cancer Treatments

For Immediate Release: June 27, 2025 The U.S. Food and Drug Administration announced today that it has eliminated the Risk Evaluation and Mitigation Strategies (REMS) for currently approved BCMA- and CD19-directed autologous chimeric antigen receptor CAR T cell immunotherapies. These products are gene therapies that are currently approved to treat blood cancers,...

FDA Cracks Down on Dangerous 7-OH Opioid Products

FDA Cracks Down on Dangerous 7-OH Opioid Products

For Immediate Release: July 29, 2025 The U.S. Food and Drug Administration today is taking a bold step to protect Americans from dangerous, illegal opioids by recommending a scheduling action to control certain 7-hydroxymitragynine (also known as 7-OH ) products under the Controlled Substances Act (CSA). The FDA is specifically targeting 7-OH, a concentrated...

FDA Supports State Plans to Make Prescription Drugs Cheaper

FDA Supports State Plans to Make Prescription Drugs Cheaper

For Immediate Release: May 21, 2025 The U.S. Food and Drug Administration is continuing to take steps to help state importation programs provide safe, effective and more affordable drugs for American patients, as part of its efforts to implement Executive Order Lowering Drug Prices by Once Again Putting Americans First. Today, the agency is announcing enhancements...

FDA Steps In: Fluoride Drugs for Kids to Be Removed

FDA Steps In: Fluoride Drugs for Kids to Be Removed

For Immediate Release: May 13, 2025 The U.S. Food and Drug Administration (FDA) today announced that it is initiating action to remove concentrated ingestible fluoride prescription drug products for children from the market. Unlike toothpaste with fluoride or fluoride rinses, these products are swallowed and ingested by infants and toddlers. They have also never...